Technology Jul 20, 2026 · 1 min read

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

TE
TechCrunch
by Marina Temkin
Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
Back to Discover

Reading List